The Lens Pod podcast

The Lens Newsletter: January 28, 2026

28.1.2026
0:00
11:22
Spol 15 sekunder tilbage
Spol 15 sekunder frem

Too busy to read the Lens? Listen to our weekly summary here! In this week’s episode we discuss…

  • When the American Joint Committee on Cancer’s classification for uveal melanoma is challenged, a new staging system is proposed that incorporates tumor volume, clinical risk factors, and genetic alterations.
  • GLP-1 receptor agonists are linked to a >90% reduced risk over 10 years of developing nonexudative age-related macular degeneration when compared to other weight-loss drugs in obese, non-diabetic individuals.
  • Migraines are independently associated with higher rates of central serous chorioretinopathy when compared to controls.
  • Eye drops containing siRNA (GalNAc-modified siHOTAIR) are comparable to anti-VEGF injections, suppressing inflammation, vascular mediators, endothelial permeability, and angiogenesis in diabetic rats.

Flere episoder fra "The Lens Pod"